Mechanisms of action of and resistance to antitubulin agents: microtubule dynamics, drug transport, and cell death.
暂无分享,去创建一个
[1] G. Millot,et al. Estramustine resistance correlates with tau over‐expression in human prostatic carcinoma cells , 1998, International journal of cancer.
[2] V. Georgoulias,et al. Salvage chemotherapy with paclitaxel, vinorelbine, and cisplatin (PVC) in anthracycline-resistant advanced breast cancer. , 1998, American journal of clinical oncology.
[3] D. Braguer,et al. Effect of microtubule disruption on cell adhesion and spreading. , 1998, Biochemical and biophysical research communications.
[4] F. Fitzpatrick,et al. Taxane-mediated gene induction is independent of microtubule stabilization: induction of transcription regulators and enzymes that modulate inflammation and apoptosis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[5] A. Levine,et al. The role of MAP4 expression in the sensitivity to paclitaxel and resistance to vinca alkaloids in p53 mutant cells , 1998, Oncogene.
[6] M. Jordan,et al. Microtubules and actin filaments: dynamic targets for cancer chemotherapy. , 1998, Current opinion in cell biology.
[7] C. Stein,et al. Taxol and estramustine-induced modulation of human prostate cancer cell apoptosis via alteration in bcl-xL and bak expression. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[8] G L Rosner,et al. Modulation of vinblastine resistance in metastatic renal cell carcinoma with cyclosporine A or tamoxifen: a cancer and leukemia group B study. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[9] R. Himes,et al. Mechanism of action of the unusually potent microtubule inhibitor cryptophycin 1. , 1997, Biochemistry.
[10] M. Kavallaris,et al. Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes. , 1997, The Journal of clinical investigation.
[11] P. Fumoleau,et al. Docetaxel in combination with doxorubicin or vinorelbine. , 1997, European journal of cancer.
[12] V. Miller. Docetaxel (Taxotere) and vinorelbine in the treatment of advanced non-small cell lung cancer: preliminary results of a phase I/II trial. , 1997, Seminars in oncology.
[13] T. Fojo,et al. Paclitaxel-resistant Human Ovarian Cancer Cells Have Mutant β-Tubulins That Exhibit Impaired Paclitaxel-driven Polymerization* , 1997, The Journal of Biological Chemistry.
[14] W. B. Derry,et al. Taxol differentially modulates the dynamics of microtubules assembled from unfractionated and purified beta-tubulin isotypes. , 1997, Biochemistry.
[15] A. Photiou,et al. In vitro synergy of paclitaxel (Taxol) and vinorelbine (navelbine) against human melanoma cell lines. , 1997, European journal of cancer.
[16] K. Tew,et al. Interaction of estramustine with tubulin isotypes. , 1997, Biochemistry.
[17] J. Bulinski,et al. Overexpression of full- or partial-length MAP4 stabilizes microtubules and alters cell growth. , 1997, Journal of cell science.
[18] A. Levine,et al. Wild-type p53 negatively regulates the expression of a microtubule-associated protein. , 1996, Genes & development.
[19] R. Flavell,et al. Double knockout of the MRP gene leads to increased drug sensitivity in vitro. , 1996, Cancer research.
[20] G. Viale,et al. The microtubule-affecting drug paclitaxel has antiangiogenic activity. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.
[21] T. Fojo,et al. Paclitaxel (Taxol(R)) inhibits motility of paclitaxel-resistant human ovarian carcinoma cells. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.
[22] F. Muggia,et al. Severe neurotoxicity from vinorelbine-paclitaxel combinations. , 1996, Journal of the National Cancer Institute.
[23] Christophe Ampe,et al. Pathway Leading to Correctly Folded β-Tubulin , 1996, Cell.
[24] K. Tew,et al. Increase of βIII- and βIVa-Tubulin Isotypes in Human Prostate Carcinoma Cells as a Result of Estramustine Resistance , 1996 .
[25] W. B. Derry,et al. Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. , 1996, Cancer research.
[26] G. Demers,et al. Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents. , 1996, Cancer research.
[27] H. Rosenkranz,et al. Discodermolide, a cytotoxic marine agent that stabilizes microtubules more potently than taxol. , 1996, Biochemistry.
[28] M. Haber,et al. Altered Expression of M2, the Class II -Tubulin Isotype, in a Murine J774.2 Cell Line with a High Level of Taxol Resistance (*) , 1995, The Journal of Biological Chemistry.
[29] R. Tishler,et al. Microtubule-active drugs taxol, vinblastine, and nocodazole increase the levels of transcriptionally active p53. , 1995, Cancer research.
[30] L. Neckers,et al. Taxol induction of p21WAF1 and p53 requires c-raf-1. , 1995, Cancer research.
[31] D. Brown,et al. Effects of taxol on the polymerization and posttranslational modification of class III beta-tubulin in P19 embryonal carcinoma cells. , 1995, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[32] P. Wadsworth,et al. Vinblastine suppresses dynamics of individual microtubules in living interphase cells. , 1995, Molecular biology of the cell.
[33] M. Jordan,et al. Microtubule dynamics: taking aim at a moving target. , 1995, Chemistry & biology.
[34] F. Kaye,et al. The N-terminal domain of c-Myc associates with alpha-tubulin and microtubules in vivo and in vitro , 1995, Molecular and cellular biology.
[35] C. Miller,et al. Vinorelbine tartrate and paclitaxel combinations: enhanced activity against in vivo P388 murine leukemia cells. , 1995, Journal of the National Cancer Institute.
[36] E. Lazarides,et al. Taxol-Induced Mitotic Block Triggers Rapid Onset of a p53-Independent Apoptotic Pathway , 1995, Molecular medicine.
[37] A. Frankfurter,et al. Binding of vinblastine to phosphocellulose-purified and alpha beta-class III tubulin: the role of nucleotides and beta-tubulin isotypes. , 1995, Biochemistry.
[38] M. Clarke,et al. Overexpression of Bcl-XS sensitizes MCF-7 cells to chemotherapy-induced apoptosis. , 1995, Cancer research.
[39] R. Maccioni,et al. Identification of a new microtubule-interacting protein Mip-90. , 1995, European Journal of Cell Biology.
[40] E. Lazarides,et al. Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action. , 1995, Cancer research.
[41] E. Hamel,et al. Interaction of dolastatin 10 with tubulin: induction of aggregation and binding and dissociation reactions. , 1995, Molecular pharmacology.
[42] M. Abeloff. Vinorelbine (Navelbine) in the treatment of breast cancer: a summary. , 1995, Seminars in oncology.
[43] W. B. Derry,et al. Substoichiometric binding of taxol suppresses microtubule dynamics. , 1995, Biochemistry.
[44] J. Forrest,et al. Protein kinase C zeta is associated with the mitotic apparatus in primary cell cultures of the shark rectal gland. , 1994, The Journal of biological chemistry.
[45] D. Panda,et al. Microtubule dynamics in vitro are regulated by the tubulin isotype composition. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[46] G. M. Wilson,et al. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. , 1994, Cancer research.
[47] A. Santoro,et al. Vinorelbine: an active drug for the management of patients with heavily pretreated Hodgkin's disease. , 1994, Annals of oncology : official journal of the European Society for Medical Oncology.
[48] C. Coltman. Vinorelbine (Navelbine)--a new agent for the treatment of non-small cell lung cancer: a summary. , 1994, Seminars in oncology.
[49] H. Hotani,et al. Microtubule-stabilizing activity of microtubule-associated proteins (MAPs) is due to increase in frequency of rescue in dynamic instability: shortening length decreases with binding of MAPs onto microtubules. , 1994, Cell structure and function.
[50] D. Golan,et al. Microtubule inhibitors differentially affect translational movement, cell surface expression, and endocytosis of transferrin receptors in K562 cells , 1994, Journal of cellular physiology.
[51] C. Smith,et al. Cryptophycin: a new antimicrotubule agent active against drug-resistant cells. , 1994, Cancer research.
[52] C. Mioskowski,et al. Predominant labeling of beta- over alpha-tubulin from porcine brain by a photoactivatable taxoid derivative. , 1994, Biochemistry.
[53] M. Jordan,et al. Removal of the projection domain of microtubule-associated protein 2 alters its interaction with tubulin , 1994, Journal of protein chemistry.
[54] I. Ringel,et al. 3'-(p-azidobenzamido)taxol photolabels the N-terminal 31 amino acids of beta-tubulin. , 1994, The Journal of biological chemistry.
[55] M. Jordan,et al. Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[56] T. Kishimoto,et al. Association of p34cdc2/cyclin B complex with microtubules in starfish oocytes. , 1993, Journal of cell science.
[57] S. Hahn,et al. Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity. , 1993, Cancer research.
[58] R. Williams,et al. Taxol-induced flexibility of microtubules and its reversal by MAP-2 and Tau. , 1993, The Journal of biological chemistry.
[59] B. Coiffier,et al. Long-term outcome and sequelae in aggressive lymphoma patients treated with the LNH-80 regimen. , 1992, Annals of oncology : official journal of the European Society for Medical Oncology.
[60] K. Tew,et al. Combined antimicrotubule activity of estramustine and taxol in human prostatic carcinoma cell lines. , 1992, Cancer research.
[61] M. Jordan,et al. Effects of vinblastine, podophyllotoxin and nocodazole on mitotic spindles. Implications for the role of microtubule dynamics in mitosis. , 1992, Journal of cell science.
[62] V. Ling. P‐glycoprotein and resistance to anticancer drugs , 1992 .
[63] Yixian Zheng,et al. γ-Tubulin is present in Drosophila melanogaster and homo sapiens and is associated with the centrosome , 1991, Cell.
[64] M. Jordan,et al. Mechanism of inhibition of cell proliferation by Vinca alkaloids. , 1991, Cancer research.
[65] S. Barlow,et al. Resistance to antimitotic drugs in Chinese hamster ovary cells correlates with changes in the level of polymerized tubulin. , 1991, The Journal of biological chemistry.
[66] A. Newland,et al. INFUSION OF VINCRISTINE AND DOXORUBICIN WITH ORAL DEXAMETHASONE AS FIRST-LINE THERAPY FOR MULTIPLE MYELOMA , 1989, The Lancet.
[67] S. Barlow,et al. Mechanisms by which mammalian cells acquire resistance to drugs that affect microtubule assembly , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[68] S. Barlow,et al. Elimination of permeability mutants from selections for drug resistance in mammalian cells , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[69] D. Cleveland,et al. In vivo microtubules are copolymers of available beta-tubulin isotypes: localization of each of six vertebrate beta-tubulin isotypes using polyclonal antibodies elicited by synthetic peptide antigens , 1987, The Journal of cell biology.
[70] W. Gu,et al. Free intermingling of mammalian β-tubulin isotypes among functionally distinct microtubules , 1987, Cell.
[71] I. Pastan,et al. Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[72] Paul R. Dobner,et al. Alternative 5' exons either provide or deny an initiator methionine codon to the same alpha-tubulin coding region , 1987, Nucleic Acids Res..
[73] A. Villasanté,et al. Six mouse alpha-tubulin mRNAs encode five distinct isotypes: testis-specific expression of two sister genes , 1986, Molecular and cellular biology.
[74] K. Sullivan,et al. Identification of conserved isotype-defining variable region sequences for four vertebrate beta tubulin polypeptide classes. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[75] C. Spurr,et al. Single agent vincristine by infusion in refractory multiple myeloma. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[76] B I Sikic,et al. Multidrug (pleiotropic) resistance in doxorubicin-selected variants of the human sarcoma cell line MES-SA. , 1985, Cancer research.
[77] I. Maclennan,et al. Objective evaluation of the role of vincristine in induction and maintenance therapy for myelomatosis. Medical Research Council Working Party on Leukaemia in Adults. , 1985, British Journal of Cancer.
[78] M. Jordan,et al. Interaction of reduced glutathione with bovine brain tubulin. , 1985, Biochemical and biophysical research communications.
[79] J. Hall,et al. Three expressed sequences within the human beta-tubulin multigene family each define a distinct isotype. , 1985, Journal of molecular biology.
[80] M. Kirschner,et al. A polymer-dependent increase in phosphorylation of beta-tubulin accompanies differentiation of a mouse neuroblastoma cell line , 1985, The Journal of cell biology.
[81] M. Kirschner,et al. Dynamic instability of microtubule growth , 1984, Nature.
[82] K. Farrell,et al. Tubulin-colchicine complexes differentially poison opposite microtubule ends. , 1984, Biochemistry.
[83] J. Riordan,et al. Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. , 1983, Science.
[84] P. Binkley,et al. beta 2-Tubulin, a form of chordate brain tubulin with lesser reactivity toward an assembly-inhibiting sulfhydryl-directed cross-linking reagent. , 1982, Biochemistry.
[85] F. Malkinson. Colchicine. New uses of an old, old drug. , 1982, Archives of dermatology.
[86] M. G. Lee,et al. Evidence that a human β-tubulin pseudogene is derived from its corresponding mRNA , 1982, Nature.
[87] J Parness,et al. Taxol binds to polymerized tubulin in vitro , 1981, The Journal of cell biology.
[88] M. Gottesman,et al. Isolation of a taxol-resistant Chinese hamster ovary cell mutant that has an alteration in alpha-tubulin. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[89] M. Gottesman,et al. CHO mutants resistant to colchicine, colcemid or griseofulvin have an altered β-tubulin , 1980, Cell.
[90] R. Margolis,et al. Opposite end assembly and disassembly of microtubules at steady state in vitro , 1978, Cell.
[91] M. Kirschner,et al. Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin. , 1977, Journal of molecular biology.
[92] I. Meza,et al. THE MECHANISM OF ACTION OF COLCHICINE , 1973, The Journal of cell biology.
[93] E. Nogales,et al. Structure of the alpha beta tubulin dimer by electron crystallography. , 1998, Nature.
[94] R. Luduena. Multiple forms of tubulin: different gene products and covalent modifications. , 1998, International review of cytology.
[95] G. Demers,et al. Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis , 1996, Nature Medicine.
[96] J Vandekerckhove,et al. Pathway leading to correctly folded beta-tubulin. , 1996, Cell.
[97] B. Sikic,et al. Novel mechanism of resistance to paclitaxel (Taxol) in human K562 leukemia cells by combined selection with PSC 833. , 1995, Oncology research.
[98] J. Reed,et al. High levels of p26BCL-2 oncoprotein retard taxol-induced apoptosis in human pre-B leukemia cells. , 1994, Leukemia.
[99] T. Mitchison,et al. Dynamics of microtubule assembly in vivo , 1994 .
[100] C. Echeverri,et al. Differential sorting of beta tubulin isotypes into colchicine-stable microtubules during neuronal and muscle differentiation of embryonal carcinoma cells. , 1992, Cell motility and the cytoskeleton.
[101] E. Hamel. Natural products which interact with tubulin in the vinca domain: maytansine, rhizoxin, phomopsin A, dolastatins 10 and 15 and halichondrin B. , 1992, Pharmacology & therapeutics.
[102] V. Ling. Charles F. Kettering Prize. P-glycoprotein and resistance to anticancer drugs. , 1992, Cancer.
[103] S B Hastie,et al. Interactions of colchicine with tubulin. , 1991, Pharmacology & therapeutics.
[104] C. Keith,et al. Neurite elongation is blocked if microtubule polymerization is inhibited in PC12 cells. , 1990, Cell motility and the cytoskeleton.
[105] M. Little,et al. Comparative analysis of tubulin sequences. , 1988, Comparative biochemistry and physiology. B, Comparative biochemistry.
[106] M. Kirschner. Microtubule assembly and nucleation. , 1978, International review of cytology.